ENvue Medical | Enteral Navigation ＆ SAW Therapeutic Solutions

admin 4 2026-05-09 17:01:50

Company Profile

ENvue Medical, Inc. is a US-based medical technology company specializing in minimally invasive navigation systems and non-invasive therapeutic devices, headquartered in Tyler, Texas, United States, with research and development facilities in Tel-Aviv and Nesher, Israel, and ENvue Navigation Platform offices in 762 West Algonquin Road, Arlington Heights, Illinois 60005, United States. The enteral navigation division was founded in 2019 by Doron Besser, MD as Envizion Medical, later rebranded as ENvue Medical. In February 2025, the company was acquired by NanoVibronix, Inc. and now operates as a subsidiary under the NanoVibronix umbrella. In December 2025, the parent company changed its name to ENvue Medical, Inc. and its ticker to NASDAQ (FEED). The company is led by CEO Doron Besser, MD and Chairman David Johnson, serving hospitals, critical care units and home care settings across the United States. The company employs approximately 15 staff and its navigation systems are currently deployed at 38 hospitals nationwide.

Core Products ＆ Technologies

ENvue™ Navigation Platform

• ENvue® System: An FDA 510(k)-cleared electromagnetic navigation system for adult enteral feeding tube placement, providing real-time bedside visualization of tube movement via body mapping and integrated sensors
• ENvue® Feeding Tube: A proprietary feeding tube with built-in passive sensor, responsive torqueability and pushability, enabling post-procedure position check without stylet re-insertion
• ENvue® OTC ENFit Syringes: An over-the-counter reusable ENFit syringe line launched in January 2026 for feeding and medication delivery across clinical and home settings without prescription

Acoustic-Based Therapeutic Devices

• PainShield®: A portable low-intensity surface acoustic wave (SAW) device for non-opioid pain relief in home or care settings
• UroShield®: A SAW technology device designed to reduce bacterial colonization and disrupt biofilms on urinary catheters

Software ＆ Navigation Technology

• True Body Navigation: Proprietary electromagnetic body mapping registering multiple sensors to anatomical landmarks for personalized patient airway and upper GI tract visualization
• Lung Safety Alerts: Graphical and text alerts signaling potential airway entrance during tube placement

Market Position ＆ Certifications

ENvue Medical holds a specialized position in the enteral access navigation and non-invasive therapy markets, competing with Medtronic and Avanos Medical in enteral feeding solutions. Key strengths include:

• 7+ years of clinical innovation in electromagnetic navigation for enteral access
• Patient safety focus: Addresses the global feeding tube lung misplacement risk through real-time bedside visualization
• Regulatory compliance: FDA 510(k) cleared for adult enteral feeding tube placement
• Clinical validation: Full alignment demonstrated between post-procedural X-ray and ENvue screen positioning, reducing repeated X-ray confirmation needs
• Intellectual property: USPTO patent allowance in February 2026 for feeding tube design integrating electromagnetic navigation with distal-tip camera; May 2026 allowance for ultrasound-enhanced cannabinoid drug delivery technology

Corporate Timeline

2019 — Founded as Envizion Medical by Doron Besser, MD, developing electromagnetic navigation technology for enteral feeding tube placement
2025 — Acquired by NanoVibronix, Inc.; first formal system adoption in the northeastern United States through a regional acute care hospital agreement
2025 — Granted U.S. patent for electromagnetic navigation in pediatric feeding tube placement
2025 — Appoints David Johnson as Chairman of the Board
2025 — Company renamed ENvue Medical, Inc. with NASDAQ ticker FEED effective December 12
2026 — Rings the Nasdaq Opening Bell on January 14, marking the company's public market milestone
2026 — Appoints Marc Waldman as Vice President, Commercial
2026 — Launches over-the-counter ENFit Syringes and signs U-Deliver distribution agreement
2026 — Launches patient comfort program for indwelling nasogastric tubes using vibration-based technology
2026 — Receives USPTO Notice of Allowance for innovative feeding tube patent with integrated camera and electromagnetic navigation
2026 — Secures USPTO allowance for ultrasound-enhanced cannabinoid drug delivery technology patent

Target Markets ＆ Applications

• Critical Care Enteral Access: ENvue System for bedside nasoenteric feeding tube placement in ICU, step-down and medical-surgical units
• Home Enteral Care: OTC ENFit Syringes and feeding accessories supporting continuity of care from hospital to home
• Non-Opioid Pain Management: PainShield for chronic and acute pain treatment in home and clinical settings
• Urinary Catheter Care: UroShield for biofilm disruption and bacterial colonization reduction on indwelling urinary devices
• Pediatric ＆ Vascular Expansion: Future platform expansion under development for pediatric feeding tube and vascular access applications